ARTICLE | Company News
SkyePharma, Sanofi sales and marketing update
April 17, 2000 7:00 AM UTC
SKP partner Sanofi-Synthelabo launched Xatral XL sustained release once daily formulation of alfuzosin in Europe and the U.K. to treat symptoms of benign prostatic hypertrophy. The product uses SKP's...